Journal of Clinical Medicine (Mar 2023)

Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions

  • Francesca Girolami,
  • Alessia Gozzini,
  • Eszter Dalma Pálinkás,
  • Adelaide Ballerini,
  • Alessia Tomberli,
  • Katia Baldini,
  • Alberto Marchi,
  • Mattia Zampieri,
  • Silvia Passantino,
  • Giulio Porcedda,
  • Giovanni Battista Calabri,
  • Elena Bennati,
  • Gaia Spaziani,
  • Lia Crotti,
  • Franco Cecchi,
  • Silvia Favilli,
  • Iacopo Olivotto

DOI
https://doi.org/10.3390/jcm12072489
Journal volume & issue
Vol. 12, no. 7
p. 2489

Abstract

Read online

Genetic counselling and genetic testing in hypertrophic cardiomyopathy (HCM) represent an integral part of the diagnostic algorithm to confirm the diagnosis, distinguish it from phenocopies, and suggest tailored therapeutic intervention strategies. Additionally, they enable cascade genetic testing in the family. With the implementation of Next Generation Sequencing technologies (NGS), the interpretation of genetic data has become more complex. In this regard, cardiologists play a central role, aiding geneticists to correctly evaluate the pathogenicity of the identified genetic alterations. In the ideal setting, geneticists and cardiologists must work side by side to diagnose HCM as well as convey the correct information to patients in response to their many questions and concerns. After a brief overview of the role of genetics in the diagnosis of HCM, we present and discuss the frequently asked questions by HCM patients throughout our 20-year genetic counselling experience. Appropriate communication between the team and the families is key to the goal of delivering the full potential of genetic testing to our patients.

Keywords